AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9784666 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO therapy in iron-replete patients
Number of subjects: 70
Study 7722901 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sealing clear corneal incisions (3.5 mm and 5.2 mm)
Number of subjects: 0
Study 7722901 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneoscleral tunnel incisions (3.5 mm and 5.2 mm)
Number of subjects: 0
Study 7722901 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal clear corneal incisions
Number of subjects: 0
Study 7722901 — intervention group
Group type: EXPERIMENTAL
Intervention: Superior clear corneal incisions
Number of subjects: 0
Study 7722901 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.2 mm frown incisions
Number of subjects: 0
Study 7722901 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear corneal incisions
Number of subjects: 0
Study 2816798 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning tests
Number of subjects: 10
Study 2816798 — intervention group
Group type: COMPARATOR
Intervention: Afternoon tests
Number of subjects: 10
Study 330474 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 or more metastatic lymph nodes
Number of subjects: 0
Study 330474 — intervention group
Group type: COMPARATOR
Intervention: 1-3 metastatic lymph nodes
Number of subjects: 0
Study 30236104 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation (PR) program for 6 months
Number of subjects: 60
Study 30236104 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care (control)
Number of subjects: 60
Study 26649464 — intervention group
Group type: EXPERIMENTAL
Intervention: ARC intervention
Number of subjects: 475
Study 26649464 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 475
Study 24144964 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical hypothyroidism (n=20, 6.5%)
Number of subjects: 307
Study 24144964 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical hyperthyroidism (n=5, 1.6%)
Number of subjects: 307
Study 24144964 — intervention group
Group type: COMPARATOR
Intervention: Euthyroid subjects (n=280, 91.8%)
Number of subjects: 307
Study 24144964 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality risk (TSH values and thyroid disorders)
Number of subjects: 307
Study 24144964 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality (n=51, 15.1%)
Number of subjects: 307
Study 23194310 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof ReSTOR SN6AD1 IOL (multifocal IOL)
Number of subjects: 102
Study 23194310 — intervention group
Group type: COMPARATOR
Intervention: AcrySof IQ SN60WF IOL (monofocal IOL)
Number of subjects: 102
Study 20712736 — intervention group
Group type: EXPERIMENTAL
Intervention: Few competitors during referent selection
Number of subjects: 30
Study 20712736 — intervention group
Group type: COMPARATOR
Intervention: Two, three, or four competitors during referent selection
Number of subjects: 30
Study 17403704 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystatin C (cysC) formula for estimating residual glomerular filtration rate (rGFR)
Number of subjects: 465
Study 17403704 — intervention group
Group type: COMPARATOR
Intervention: Modification of Diet in Renal Disease (MDRD) formula
Number of subjects: 465
Study 16422873 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 31
Study 16422873 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate 40 mg
Number of subjects: 31
Study 16422873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 11843276 — intervention group
Group type: EXPERIMENTAL
Intervention: RME only (Group I)
Number of subjects: 34
Study 11843276 — intervention group
Group type: EXPERIMENTAL
Intervention: RME with vertical chin cap (Group II)
Number of subjects: 34
Study 10411372 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in hematocrit by 10.99%
Number of subjects: 32
Study 10411372 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased viscosity by 20%
Number of subjects: 32
Study 10411372 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiologic compensation for 20% increased viscosity
Number of subjects: 32
Study 7572595 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem controlled diffusion (CD) 300 mg
Number of subjects: 43
Study 7572595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 2258341 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin (800 mg single dose)
Number of subjects: 155
Study 2258341 — intervention group
Group type: COMPARATOR
Intervention: Co-trimoxazole (960 mg twice daily for 5 days)
Number of subjects: 155
Study 7273010 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly regimen of PALA and 5-FU (24 patients)
Number of subjects: 51
Study 7273010 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day regimen of PALA and 5-FU (27 patients)
Number of subjects: 51
Study 7273010 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment regimens
Number of subjects: 51
Study 31429663 — intervention group
Group type: EXPERIMENTAL
Intervention: One Man Can, a gender-transformative community mobilisation programme
Number of subjects: 0
Study 31576435 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-lung ventilation strategy (ventilation during CPB, higher PEEP levels of 8 cm H2O)
Number of subjects: 493
Study 31576435 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation strategy (no ventilation during CPB, lower PEEP levels of 2 cm H2O)
Number of subjects: 493
Study 31576435 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-lung ventilation
Number of subjects: 493
Study 31576435 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 493
Study 27453426 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-speed rotational atherectomy (140,000 rpm)
Number of subjects: 100
Study 27453426 — intervention group
Group type: COMPARATOR
Intervention: High-speed rotational atherectomy (190,000 rpm)
Number of subjects: 100
Study 25607727 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine XR
Number of subjects: 133
Study 25607727 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 23359467 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 32
Study 23359467 — intervention group
Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 32
Study 21422852 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional management with self blood glucose monitoring and insulin as needed
Number of subjects: 460
Study 19272069 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative low-molecular-weight heparin (LMWH)
Number of subjects: 148
Study 19272069 — intervention group
Group type: COMPARATOR
Intervention: No postoperative low-molecular-weight heparin (LMWH)
Number of subjects: 148
Study 19272069 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH the night before surgery
Number of subjects: 148
Study 19272069 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Number of subjects: 148
Study 19272069 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 148
Study 16945373 — intervention group
Group type: EXPERIMENTAL
Intervention: Thr‐54 polymorphism of the FABP2 gene
Number of subjects: 776
Study 15088307 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir
Number of subjects: 60
Study 15088307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 10573065 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab (40 mg total: 20 mg on days 0 and 4)
Number of subjects: 169
Study 8791885 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin 0.05% emollient cream (Retinova ‐ Janssen‐Cilag Ltd)
Number of subjects: 0
Study 1826988 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural injection of 10-30 micrograms sufentanil added to 0.125% bupivacaine with epinephrine (1:800,000)
Number of subjects: 695
Study 1826988 — intervention group
Group type: COMPARATOR
Intervention: Epidural injection of 0.125% bupivacaine with epinephrine (1:800,000) without sufentanil
Number of subjects: 695
Study 10258418 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-teaching module
Number of subjects: 34
Study 10258418 — intervention group
Group type: COMPARATOR
Intervention: Group instruction
Number of subjects: 34
Study 31277633 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity assessment using Global Physical Activity Questionnaire (GPAQ)
Number of subjects: 945
Study 31277633 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO recommendations of physical activity
Number of subjects: 945
Study 31277633 — intervention group
Group type: EXPERIMENTAL
Intervention: Recreational activities
Number of subjects: 945
Study 31277633 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlates of low physical activity
Number of subjects: 945
Study 28619295 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy (one hour a week during four weeks)
Number of subjects: 29
Study 24513469 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorography
Number of subjects: 50
Study 24513469 — intervention group
Group type: COMPARATOR
Intervention: Cineangiography
Number of subjects: 50
Study 22577906 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 2.5 mg
Number of subjects: 117
Study 22577906 — intervention group
Group type: COMPARATOR
Intervention: Morphine 7.5 mg
Number of subjects: 117
Study 19937504 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 103
Study 19937504 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 18008122 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 80
Study 18008122 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 80
Study 18008122 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 80
Study 18008122 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline
Number of subjects: 80
Study 16153525 — intervention group
Group type: EXPERIMENTAL
Intervention: Color M-mode Doppler assessment of early (Ep) and late (Ap) flow propagation through the left ventricle.
Number of subjects: 80
Study 16153525 — intervention group
Group type: EXPERIMENTAL
Intervention: Color M-mode Doppler assessment of early (Ep) and late (Ap) flow propagation through the left ventricle in patients with PSN filling pattern.
Number of subjects: 80
Study 16153525 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (50 subjects).
Number of subjects: 80
Study 12653169 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg zafirlukast b.i.d.
Number of subjects: 52
Study 12653169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 10529020 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone with buprenorphine taper (NB Group)
Number of subjects: 60
Study 10529020 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine taper alone followed by naltrexone (PB Group)
Number of subjects: 60
Study 10529020 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (NB Group)
Number of subjects: 60
Study 10529020 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PB Group)
Number of subjects: 60
Study 10529020 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunct medication (clonidine)
Number of subjects: 60
Study 10529020 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedatives (up to 20 mg diazepam)
Number of subjects: 60
Study 10529020 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone combined with buprenorphine
Number of subjects: 60
Study 8787262 — intervention group
Group type: EXPERIMENTAL
Intervention: Portex combined spinal-epidural kit
Number of subjects: 100
Study 8787262 — intervention group
Group type: COMPARATOR
Intervention: Mallinckrodt combined spinal-epidural kit
Number of subjects: 100
Study 2032147 — intervention group
Group type: EXPERIMENTAL
Intervention: Alutard SQ (grass pollen depot preparation)
Number of subjects: 0
Study 6354507 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine (1000 mg given in one day)
Number of subjects: 99
Study 6354507 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (1500 mg given over 3 days)
Number of subjects: 99
Study 31826920 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate femoral cutaneous nerve blockade (IFCNB) combined with proximal femoral triangle block (FTB)
Number of subjects: 40
Study 31826920 — intervention group
Group type: COMPARATOR
Intervention: Proximal femoral triangle block (FTB) alone
Number of subjects: 40
Study 31826920 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal femoral triangle block (FTB) combined with IFCNB
Number of subjects: 40
Study 31826920 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal femoral triangle block (FTB) combined with IFCNB
Number of subjects: 40
Study 29543552 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher score on the Anglo orientation scale of the Acculturation Rating Scale for Mexican Americans
Number of subjects: 150
Study 29178740 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine-based professional paste and arginine-based toothpaste
Number of subjects: 60
Study 29178740 — intervention group
Group type: COMPARATOR
Intervention: Fluoride-free prophylaxis paste and sodium monofluorophosphate toothpaste
Number of subjects: 60
Study 27129120 — intervention group
Group type: EXPERIMENTAL
Intervention: Test product (20 mg piroxicam capsule)
Number of subjects: 24
Study 27129120 — intervention group
Group type: COMPARATOR
Intervention: Reference product (20 mg piroxicam capsule)
Number of subjects: 24
Study 22184099 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination
Number of subjects: 20
Study 20646771 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey dressing applied to wounds for 3 months till healing, grafting or failure of treatment.
Number of subjects: 30
Study 17257466 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous combined hormone replacement therapy (ccHRT) (Indivina)
Number of subjects: 0
Study 17257466 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest dose-combination of ccHRT
Number of subjects: 0
Study 17723039 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel word labeling
Number of subjects: 172
Study 17723039 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel gesture labeling
Number of subjects: 172
Study 17723039 — intervention group
Group type: COMPARATOR
Intervention: No label
Number of subjects: 172
Study 17723039 — intervention group
Group type: EXPERIMENTAL
Intervention: Same word labeling
Number of subjects: 172
Study 17723039 — intervention group
Group type: EXPERIMENTAL
Intervention: Same gesture labeling
Number of subjects: 172
Study 15160273 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic shocks
Number of subjects: 118
Study 15160273 — intervention group
Group type: COMPARATOR
Intervention: Monophasic shocks
Number of subjects: 118
Study 10714047 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 63
Study 10714047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 8955759 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux polysulfone membranes
Number of subjects: 20
Study 8955759 — intervention group
Group type: COMPARATOR
Intervention: Conventional low-flux HD membranes
Number of subjects: 20
Study 1597983 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol (5 micrograms/kg/min)
Number of subjects: 30
Study 1597983 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (0.08 microgram/kg/min)
Number of subjects: 30
Study 1597983 — intervention group
Group type: COMPARATOR
Intervention: Control group (no drugs)
Number of subjects: 30
Study 6230174 — intervention group
Group type: EXPERIMENTAL
Intervention: Coumadin treatment (prothrombin time 2 to 2.5 times the control value)
Number of subjects: 248
Study 6230174 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (325 mg daily)
Number of subjects: 248
Study 6230174 — intervention group
Group type: EXPERIMENTAL
Intervention: Coumadin treatment (for patients with at least a 6 month history of angina)
Number of subjects: 248
Study 6230174 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (for patients with at least a 6 month history of angina)
Number of subjects: 248
Study 30826382 — intervention group
Group type: EXPERIMENTAL
Intervention: Symmetric breathing pattern
Number of subjects: 86
Study 30826382 — intervention group
Group type: EXPERIMENTAL
Intervention: Skewed breathing pattern
Number of subjects: 86
Study 30826382 — intervention group
Group type: COMPARATOR
Intervention: Watching an emotionally neutral film (sham)
Number of subjects: 86
Study 30826382 — intervention group
Group type: EXPERIMENTAL
Intervention: Skewed vagal breathing (experimental group)
Number of subjects: 86
Study 30826382 — intervention group
Group type: COMPARATOR
Intervention: Waiting for 2 min (controls)
Number of subjects: 86
Study 29959266 — intervention group
Group type: EXPERIMENTAL
Intervention: DBS plus optimal drug therapy (DBS + ODT)
Number of subjects: 28
Study 29959266 — intervention group
Group type: COMPARATOR
Intervention: Optimal drug therapy (ODT)
Number of subjects: 28
Study 27393540 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid prophylaxis (exact dosage and duration not specified)
Number of subjects: 1351
Study 24635170 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel polyurethane foam
Number of subjects: 18
Study 24635170 — intervention group
Group type: COMPARATOR
Intervention: Control standard foam
Number of subjects: 18
Study 22266175 — intervention group
Group type: EXPERIMENTAL
Intervention: 1mg oral 17‐β estradiol
Number of subjects: 24
Study 22266175 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo pills
Number of subjects: 24
Study 19237499 — intervention group
Group type: EXPERIMENTAL
Intervention: health promotion intervention
Number of subjects: 878
Study 17458707 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based CDSS
Number of subjects: 40
Study 17458707 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper-based CDSS
Number of subjects: 40
Study 17458707 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of computer and paper-based CDSS
Number of subjects: 40
Study 17458707 — intervention group
Group type: COMPARATOR
Intervention: Computer-based CDSS in secondary care
Number of subjects: 40
Study 17458707 — intervention group
Group type: COMPARATOR
Intervention: Historical control groups in 'before and after' studies
Number of subjects: 40
Study 15814548 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (0.2 mg/kg)
Number of subjects: 205
Study 15814548 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporin microemulsion (7 mg/kg)
Number of subjects: 205
Study 15814548 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabbit anti-thymocyte globulin (rATG)
Number of subjects: 205
Study 15814548 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 205
Study 11910310 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol 50 mg/day
Number of subjects: 119
Study 11910310 — intervention group
Group type: EXPERIMENTAL
Intervention: trandolapril 2 mg/day
Number of subjects: 119
Study 11910310 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil 240 mg/day
Number of subjects: 119
Study 11910310 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil 180 + trandolapril 2 mg/day combination
Number of subjects: 119
Study 9426828 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg CPA
Number of subjects: 0
Study 9426828 — intervention group
Group type: EXPERIMENTAL
Intervention: CPA (10-150 mg)
Number of subjects: 0
Study 8131255 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine alone
Number of subjects: 20
Study 8131255 — intervention group
Group type: COMPARATOR
Intervention: Mefloquine in combination with artesunate
Number of subjects: 20
Study 8131255 — intervention group
Group type: COMPARATOR
Intervention: Artesunate effect on mefloquine pharmacokinetics
Number of subjects: 20
Study 2643892 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane at 0.5, 0.75, and 1 MAC in 60% N2O
Number of subjects: 28
Study 2643892 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane at 0.5, 0.75, and 1 MAC in 60% N2O
Number of subjects: 28
Study 2643892 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane at 0.5, 0.75, and 1 MAC in 60% N2O
Number of subjects: 28
Study 772653 — intervention group
Group type: EXPERIMENTAL
Intervention: Xanthinol nicotinate ('Complamin'; 'Complamex')
Number of subjects: 33
Study 772653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 31998472 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy (MT) consisting of two high-velocity low-amplitude spinal manipulations and two grade IV mobilizations of the lumbar spine and pelvis
Number of subjects: 40
Study 31998472 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy (MT)
Number of subjects: 40
Study 30759101 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative arts in psychotherapy (10-session group programme)
Number of subjects: 125
Study 30759101 — intervention group
Group type: COMPARATOR
Intervention: Low-level supportive programme (control condition)
Number of subjects: 125
Study 27709762 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster-acting insulin aspart (faster aspart)
Number of subjects: 48
Study 27709762 — intervention group
Group type: COMPARATOR
Intervention: Insulin aspart (IAsp)
Number of subjects: 48
Study 25649543 — intervention group
Group type: EXPERIMENTAL
Intervention: Traumeel 2 ml injection
Number of subjects: 160
Study 25649543 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg injection
Number of subjects: 160
Study 25649543 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 160
Study 24351013 — intervention group
Group type: COMPARATOR
Intervention: Distraction by STROOP test
Number of subjects: 34
Study 24351013 — intervention group
Group type: COMPARATOR
Intervention: Heterotopic foot stimulation
Number of subjects: 34
Study 24351013 — intervention group
Group type: COMPARATOR
Intervention: Heterotopic stimulation
Number of subjects: 34
Study 21406601 — intervention group
Group type: EXPERIMENTAL
Intervention: lisinopril 10 to 20 mg/d
Number of subjects: 0
Study 21406601 — intervention group
Group type: EXPERIMENTAL
Intervention: lisinopril 10 to 20 mg/d plus simvastatin 20 mg/d
Number of subjects: 0